173 related articles for article (PubMed ID: 23095717)
21. Association of p73 G4C14-A4T14 polymorphisms with genetic susceptibilities to breast cancer: a case-control study.
Zhou X; Wu C
Med Oncol; 2012 Dec; 29(5):3216-21. PubMed ID: 22535334
[TBL] [Abstract][Full Text] [Related]
22. Association of combined p73 and p53 genetic variants with tumor HPV16-positive oropharyngeal cancer.
Wang Z; Sturgis EM; Guo W; Song X; Zhang F; Xu L; Wei Q; Li G
PLoS One; 2012; 7(4):e35522. PubMed ID: 22523600
[TBL] [Abstract][Full Text] [Related]
23. Differential expression of p53 gene family members p63 and p73 in head and neck squamous tumorigenesis.
Choi HR; Batsakis JG; Zhan F; Sturgis E; Luna MA; El-Naggar AK
Hum Pathol; 2002 Feb; 33(2):158-64. PubMed ID: 11957139
[TBL] [Abstract][Full Text] [Related]
24. p73 and p63 sustain cellular growth by transcriptional activation of cell cycle progression genes.
Lefkimmiatis K; Caratozzolo MF; Merlo P; D'Erchia AM; Navarro B; Levrero M; Sbisa' E; Tullo A
Cancer Res; 2009 Nov; 69(22):8563-71. PubMed ID: 19861536
[TBL] [Abstract][Full Text] [Related]
25. Association of a p73 exon 2 G4C14-to-A4T14 polymorphism with risk of squamous cell carcinoma of the head and neck.
Li G; Sturgis EM; Wang LE; Chamberlain RM; Amos CI; Spitz MR; El-Naggar AK; Hong WK; Wei Q
Carcinogenesis; 2004 Oct; 25(10):1911-6. PubMed ID: 15180941
[TBL] [Abstract][Full Text] [Related]
26. Analysis of p73 in human borderline and invasive ovarian tumor.
Ng SW; Yiu GK; Liu Y; Huang LW; Palnati M; Jun SH; Berkowitz RS; Mok SC
Oncogene; 2000 Apr; 19(15):1885-90. PubMed ID: 10773878
[TBL] [Abstract][Full Text] [Related]
27. Common variation in EMSY and risk of breast and ovarian cancer: a case-control study using HapMap tagging SNPs.
Benusiglio PR; Lesueur F; Luccarini C; McIntosh J; Luben RN; Smith P; Dunning A; Easton DF; Ponder BA; Pharoah PD
BMC Cancer; 2005 Jul; 5():81. PubMed ID: 16029503
[TBL] [Abstract][Full Text] [Related]
28. Combined effects of p73 and MDM2 polymorphisms on the risk of lung cancer.
Jun HJ; Park SH; Lee WK; Choi JE; Jang JS; Kim EJ; Cha SI; Kim DS; Kam S; Kim CH; Kang YM; Jung TH; Park JY
Mol Carcinog; 2007 Feb; 46(2):100-5. PubMed ID: 17013834
[TBL] [Abstract][Full Text] [Related]
29. p73 G4C14-to-A4T14 polymorphism and risk of lung cancer.
Li G; Wang LE; Chamberlain RM; Amos CI; Spitz MR; Wei Q
Cancer Res; 2004 Oct; 64(19):6863-6. PubMed ID: 15466174
[TBL] [Abstract][Full Text] [Related]
30. Combined effects of the p53 codon 72 and p73 G4C14-to-A4T14 polymorphisms on the risk of HPV16-associated oral cancer in never-smokers.
Chen X; Sturgis EM; El-Naggar AK; Wei Q; Li G
Carcinogenesis; 2008 Nov; 29(11):2120-5. PubMed ID: 18701437
[TBL] [Abstract][Full Text] [Related]
31. Differential expression of p53 family proteins in colorectal adenomas and carcinomas: Prognostic and predictive values.
Bahnassy AA; Zekri AR; Salem SE; Abou-Bakr AA; Sakr MA; Abdel-Samiaa AG; Al-Bradei M
Histol Histopathol; 2014 Feb; 29(2):207-16. PubMed ID: 23996743
[TBL] [Abstract][Full Text] [Related]
32. Association of a p73 exon 2 G4C14-to-A4T14 polymorphism with risk of hepatocellular carcinoma in a Chinese population.
Deng B; Liu F; Wei Y; Luo L; Chen X; Yan L; Li B
Tumour Biol; 2013 Feb; 34(1):293-9. PubMed ID: 23065572
[TBL] [Abstract][Full Text] [Related]
33. P73 gene expression in ovarian cancer tissues and cell lines.
Chen CL; Ip SM; Cheng D; Wong LC; Ngan HY
Clin Cancer Res; 2000 Oct; 6(10):3910-5. PubMed ID: 11051237
[TBL] [Abstract][Full Text] [Related]
34. Relationship between PIWIL1 gene polymorphisms and epithelial ovarian cancer susceptibility among southern Chinese woman: a three-center case-control study.
Liu S; Yan Y; Cui Z; Feng H; Zhong F; Liu Z; Li Y; Ou X; Li W
BMC Cancer; 2023 Nov; 23(1):1149. PubMed ID: 38012622
[TBL] [Abstract][Full Text] [Related]
35. p73 G4C14 to A4T14 polymorphism is associated with colorectal cancer risk and survival.
Lee KE; Hong YS; Kim BG; Kim NY; Lee KM; Kwak JY; Roh MS
World J Gastroenterol; 2010 Sep; 16(35):4448-54. PubMed ID: 20845513
[TBL] [Abstract][Full Text] [Related]
36. Polymorphisms of p53 Arg72Pro, p73 G4C14-to-A4T14 at exon 2 and p21 Ser31Arg and the risk of non-Hodgkin's lymphoma in Japanese.
Hishida A; Matsuo K; Tajima K; Ogura M; Kagami Y; Taji H; Morishima Y; Emi N; Naoe T; Hamajima N
Leuk Lymphoma; 2004 May; 45(5):957-64. PubMed ID: 15291355
[TBL] [Abstract][Full Text] [Related]
37. Relationship between p73 polymorphism and the immunohistochemical profile of the full-length (TAp73) and NH2-truncated (ΔNp73) isoforms in Tunisian patients.
Arfaoui AT; Ben Mahmoud LK; Ben Hmida A; Khiari M; Mohamed AL; Chaar I; Khalfallah T; Regaya SM; Bouraoui S
Appl Immunohistochem Mol Morphol; 2010 Dec; 18(6):546-54. PubMed ID: 20733477
[TBL] [Abstract][Full Text] [Related]
38. A microRNA-dependent circuit controlling p63/p73 homeostasis: p53 family cross-talk meets therapeutic opportunity.
Ory B; Ellisen LW
Oncotarget; 2011 Mar; 2(3):259-64. PubMed ID: 21436470
[TBL] [Abstract][Full Text] [Related]
39. Association between single nucleotide polymorphisms (SNPs) of XRCC2 and XRCC3 homologous recombination repair genes and ovarian cancer in Polish women.
Michalska MM; Samulak D; Romanowicz H; Jabłoński F; Smolarz B
Exp Mol Pathol; 2016 Apr; 100(2):243-7. PubMed ID: 26801223
[TBL] [Abstract][Full Text] [Related]
40. Polymorphism of the p73 gene in relation to colorectal cancer risk and survival.
Pfeifer D; Arbman G; Sun XF
Carcinogenesis; 2005 Jan; 26(1):103-7. PubMed ID: 15485994
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
